Literature DB >> 14658487

Spironolactone-induced agranulocytosis: a case report.

Shu-Hwa Hsiao1, Yih-Jyh Lin, May-Ying Hsu, Ta-Jen Wu.   

Abstract

A 43-year-old woman with liver cirrhosis and hepatocellular carcinoma was admitted for the chief problem of ascites. Laboratory data revealed a leukocyte count of 3.8 x 10(9)/L on the second day of admission. Spironolactone was prescribed for diuresis beginning on the third day. Routine blood tests on the tenth day disclosed marked leukopenia (1.8 x 10(9)/L). Four days later, the leukocyte count was still 1.8 x 10(9)/L and a differential count revealed agranulocytosis (neutrophils, 0.25 x 10(9)/L). Eight days after withdrawal of spironolactone, the leukocyte count returned to normal (leukocytes, 4.9 x 109/L; neutrophils, 1.76 x 10(9)/L). On review of the patient's clinical condition, concurrent medication, and previous reports, we highly suspected that this episode of agranulocytosis was caused by spironolactone. Unlike four previously reported cases, this one did not involve furosemide, which is reported to be associated with leukopenia and agranulocytosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14658487     DOI: 10.1016/S1607-551X(09)70509-1

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  1 in total

1.  Agranulocytosis Associated With Spironolactone Therapy: A Case Report.

Authors:  Adam A Fershko; Jennifer A Neely; Alejandro R Calvo
Journal:  World J Oncol       Date:  2011-10-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.